The Preclinical Modeling shared resource at Fred Hutch is a core that supports the development and maintenance of preclinical mouse models, including patient-derived xenografts (PDX), cell-line xenografts and genetically engineered mouse models, or GEMMs. We work with investigators in the Fred Hutch/University of Washington/Seattle Children's Cancer Consortium and other institutions to enable preclinical research on cancer and other diseases.
Training Opportunities
We provide investigators in the Fred Hutch/University of Washington Cancer Consortium and at other institutions with competitively priced, high-quality services.
To learn more about training opportunities, services, our rates or how we can work with you, please contact Elizabeth Cromwell regarding patient-derived xenograft (PDX) lead or Dr. Priti Singh regarding genetically engineered mouse model (GEMM) lead.